İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

PERVİN TOPÇUOĞLU

PROFESÖR

ANKARA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Hematoloji (İç Hastalıkları)

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 266
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 54 Q2 31 Q3 36 Q4 25
WoS (JCR) Q1 18 Q2 52 Q3 27 Q4 49
TR Index 61 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 1
Üst %10 makale 6
Ort. yüzdelik 40.5%
Üst %1 payı 0.5%
Üst %10 payı 2.9%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 266 yayın

Makale listesi

OpenAlex zenginleştirme görünümü — 96 kayıt.

  1. 2025 CT-1425: Higher Pretransplant Lymphocyte Count Is Associated With Improved Survival in Allogeneic Stem Cell Transplantation With Antithymocyte Globulin Clinical Lymphoma Myeloma & Leukemia DOI 10.1016/s2152-2650(25)02875-7
  2. 2023 P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES HemaSphere DOI 10.1097/01.hs9.0000936204.00101.29 OpenAlex 55.0%
  3. 2023 A Single Center Real-World Data Comparing Salvage Autologous Hematopoietic Stem-Cell Transplantation, Selinexor Combo and Elranatamab Alone Among Triple Class Refractory Myeloma Patients: Better Efficacy with Elranatamab Blood DOI 10.1182/blood-2023-173644
  4. 2023 Trends in AL Amyloidosis: Decrease in Early Mortality, Increase in Survival but Less AHCT: Single Center Experience Transplantation and Cellular Therapy DOI 10.1016/s2666-6367(23)00605-x OpenAlex 0.9%
  5. 2023 PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR HemaSphere DOI 10.1097/01.hs9.0000977304.57128.06 OpenAlex 15.9%
  6. 2023 PB2213: RETROSPECTIVE ANALYSIS OF 45 UNSELECTED PATIENTS WITH HISTIOCYTOSIS CONFIRMS PROGNOSTIC RELEVANCE OF ORGAN INVOLVEMENT: SINGLE‐CENTER EXPERIENCE HemaSphere DOI 10.1097/01.hs9.0000975600.58393.5d OpenAlex 13.7%
  7. 2022 Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic? Transplantation and Cellular Therapy DOI 10.1016/s2666-6367(22)00500-0 OpenAlex 3.2%
  8. 2022 The Impact of CD34+ Cell and Immunefector Cell Dose on Transplant Outcomes Blood DOI 10.1182/blood-2022-155998 OpenAlex 26.8%
  9. 2021 Comparative Analysis and Validation of CIBMTR Early Relapse Risk Score with ISS and R-ISS: Single Center Experience from Ankara University Transplantation and Cellular Therapy DOI 10.1016/s2666-6367(21)00516-9 OpenAlex 1.3%
  10. 2021 Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients Transplantation and Cellular Therapy DOI 10.1016/s2666-6367(21)00343-2 OpenAlex 2.1%
  11. 2020 Relapse of Immune Thrombocytopenic Purpura in a Patient With COVID-19 Infectious Diseases and Clinical Microbiology DOI 10.36519/idcm.2020.0026 OpenAlex 19.9%
  12. 2020 Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data Transplantation and Cellular Therapy DOI 10.1016/j.bbmt.2019.12.405 OpenAlex 0.6%
  13. 2020 Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis Transplantation and Cellular Therapy DOI 10.1016/j.bbmt.2019.12.617 OpenAlex 0.6%
  14. 2020 New Agents in the Treatment of Acute Myeloid Leukemia LLM Dergi DOI 10.5578/llm.68329 OpenAlex 1.6%
  15. 2020 A Case of Acute Myeloid Leukemia Transformed from Myelodisplastic Syndrome Which Relapsed with der(1) t(1;19) Chromosomal Abnormality After Allogenic Transplantation LLM Dergi DOI 10.5578/llm.67424 OpenAlex 1.6%
  16. 2020 The Outcomes of Splenectomy and Drug Therapy in Patients with Splenic Marginal Zone Lymphoma LLM Dergi DOI 10.5578/llm.69377 OpenAlex 3.8%
  17. 2020 Allogeneic hematopoietic stem cell transplantation for primary myelofibrosis: A single-center experience. Journal of Clinical Oncology DOI 10.1200/jco.2020.38.15_suppl.e19522
  18. 2020 A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm. Journal of Clinical Oncology DOI 10.1200/jco.2020.38.15_suppl.e19536
  19. 2020 COVID-19 ve İlaç/Aşı Klinik Çalışmaları Türkiye Klinikleri COVID - 19 OpenAlex 13.3%
  20. 2020 Bir Nakil Merkezinin 11 Yıllık Allojeneik Kök Hücre Nakli Deneyimi LLM Dergi DOI 10.5578/llm.70231 OpenAlex 15.9%

Akademisyenlere dön